Nanosonics Adds Olympus Veteran To Board As It Targets Multi-Platform Growth
NAN: $2.92 +1.39% · MC: $841M
Nanosonics appointed Julien Sauvagnargues, formerly President and CEO of Olympus’s Americas region, as an independent non-executive director from December, citing his medical technology and endoscopy experience as it advances its CORIS system alongside its trophon business. At its AGM, the company said FY26 revenue grew 3% as reported and 6% in constant currency, while constant-currency EBIT rose 21%; it also reiterated an on-market buy-back of up to $40 million for FY27. Shareholders carried all resolutions listed in the AGM results, including director elections and approvals for executive incentive awards.

Comments